Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline June 1, 2017
GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early April 20, 2017
Axial Therapeutics Launches to Treat Patients with CNS Disorders by Harnessing the Gut Microbiome November 30, 2016
KalVista Pharmaceuticals Raises $33 Million to Advance Development of Novel Plasma Kallikrein Inhibitors in Diabetic Macular Edema and Hereditary Angioedema July 22, 2015
